Latest News
Cascadia Capital, a diversified boutique investment bank serving both private and public growth companies, has served as the exclusive financial advisor to Chelmsford, MA based FRX Polymers, Inc. (FRX or the Company) (www.frxpolymers.com) in its recent USD15.7 million growth equity financing.
FRX is a growth stage "green chemical" company that is commercialising a new non-halogen containing polymer technology that addresses an unmet market need in the USD15 billion flame retardant polymer industry. SAM Private Equity, with headquarters in Zurich, Switzerland, led the Series B round of financing. Joining SAM were the Company’s series A investors (Capricorn Venture Partners and
Regent Capital is supporting Prism the Gift Fund (‘Prism’), which has joined forces with Big Issue Invest (BII) to set up a pioneering initiative called The Big Issue Social Enterprise Investment Appeal.
This unique collaboration enables donors to claim tax relief on their charitable donations, support innovative businesses that will have a positive social impact, PLUS any returns generated can be onward gifted to other charities all over the world.
‘Prism is thrilled to be working with the Big Issue Invest on such an innovative project. We are excited by the idea of opening up the Social Investment market
The AIM-quoted private equity investor China Private Equity Holdings Ltd (CPE; Ticker CPEH) has posted a 6.9% increase in net asset valuation for the year to 31 December 2011.
The company said the increase reflected its initial positioning within China’s rapidly growing TMT sector, while a subsequent additional move into financial services has also established a presence in a market now set to benefit from the Chinese Government objective of shifting the country towards a consumer-based economy.
Consolidated net asset valuation for the year rose to USD29.3 million (2009: USD27.4 million), with net asset value per share rising in line
Bio City Development Company BV (BCDco), a leading emerging markets’ healthcare infrastructure company, and an affiliate of the Turkish housing authority, TOKi, have formed a partnership and successfully attracted foreign investment to build a state of the art tertiary care paediatric hospital with integrated research and development facilities.
BCDco has successfully completed the offering of USD200 million Convertible Bonds due 2018 (the Bonds), which may be increased by up to USD25 million prior to settlement, to finance the development of Bio City Istanbul. An affiliate of Lyrical Partners, the New York investment firm, provided significant early stage investment in BCDco.
Venture capital firm Accel Partners has led a USD50m minority investment in YapStone, a provider of Electronic Payments as a Service (ePaaS) for property management and other vertical market segments.
The new capital will be used to support the Company’s rapid growth, specifically for continued investment in its core technology platform to serve current and new vertical markets. The capital will also be used to support international expansion and fund opportunistic acquisitions. Financial Technology Partners LP and FTP Securities LLC (together "FT Partners") served as exclusive strategic and financial advisor to YapStone and its Board of Directors in this transaction.
AXA Private Equity has signed a Sale and Purchase Agreement with Citigroup (NYSE: C) for the acquisition of a USD1.7 billion portfolio of limited partnership interests in private equity buyout funds and a portfolio of direct stakes in companies. This deal represents one of the largest ever secondary private equity transactions and confirms AXA Private Equity’s world leadership in secondary Funds of Funds.
The portfolio sold by Citi Holdings comprises 207 limited partnership interests in mostly buyout and a number of investments that were made directly into certain companies. The portfolio was funded by Citigroup proprietary capital and does not
Unigestion, a leading privately owned asset manager with EUR 8.1 billion (USD 11.5 billion) of assets under management, announces the final closing of the Unigestion Secondary Opportunity Fund II at EUR 190 million, above its original target of EUR150 million, and the first closing in June of the Unigestion – Ethos Environmental Sustainability Fund.
Unigestion Secondary Opportunity II, which is already well over 50% invested, takes advantage of a window of opportunity created in 2009 to acquire private equity assets below their intrinsic value. It targets small and mid-sized transactions in the EUR 3 to 20 million range, which are
SL Capital Partners (“SL Capital”) has promoted Graeme Dunbar’s to Investment Director within the SL Capital investment team in Edinburgh.
In his new role, Dunbar will be responsible for the SL Capital investment teams primary fund investments, secondary investments and direct co-investments, with a particular focus on the Nordic Region.
Commenting on the promotion, David Currie (pictured), Chief Executive, SL Capital, says: “Amid an uncertain economic environment, 2011 is on course to be another strong year for SL Capital Partners and its investors as new investment activity levels remain high and we are seeing a significant improvement in performance and
Profit Recovery Partners (PRP) Executive Vice President Bill Carpou is departing the firm to accept a position with RGIS, a private equity-owned firm.
During his time at PRP, Carpou led the Sales Division and the expansion into new target markets inside the PRP portfolio. Prior to joining PRP, Carpou was with IKON Office Solutions for 18 years.
"Bill has been a great help in building a strong foundation for PRP to meet its future growth goals, and has helped position our company as an industry leader with unparalleled services to our clients. We appreciate the many contributions Bill has made
Northern Digital Inc (NDI), a portfolio company of Audax Group (Audax),has been sold to strategic buyer Roper Industries, Inc. (Roper;NYSE:ROP). The transaction closed on June 3, 2011. Harris Williams & Co. acted as an advisor to NDI. The transaction was led by Turner Bredrup, Todd Morris, Cheairs Porter, Andy Dixon, and Andrew Hewlett of the firm’s Healthcare & Life Sciences (HCLS) Group.
“NDI is a wonderful company with a 30-year track record of developing and producing outstanding devices to serve the global image guided surgery and other attractive life science and industrial markets. CIVCO Medical Instruments, a Roper subsidiary,
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
